HOME >> BIOLOGY >> NEWS
Progesterone therapy and preterm birth: More evidence helps identify women who can benefit

WHITE PLAINS, N.Y., AUG. 2, 2005 Two major studies published today in The New England Journal of Medicine can help doctors better identify pregnant women at risk for preterm delivery who can benefit from progesterone treatment, the March of Dimes Foundation said today.

In one large multi-center trial led by Eduardo B. Fonseca, M.D., women with short cervix (most of whom had no prior history of preterm birth) who received progesterone suppository treatment between 24 and 34 weeks gestation had a greatly reduced rate of preterm birth.

Another large multi-center trial led by Dwight J. Rouse, M.D., found that weekly injections of 17P (17 alpha-hydroxyprogesterone caproate, a derivative of progesterone) between 16 and 35 weeks gestation did not reduce the rate of preterm birth among women carrying twins.

Premature birth is a growing problem in the United States and a leading killer of newborns, said Michael Katz, senior vice president for Research and Global Programs of the March of Dimes. With this new information, physicians will have a better idea of how to identify those women who are most likely to benefit from progesterone treatment from those who are not.

Dr. Katz noted that pathways to preterm birth may differ substantially between singleton and twin gestations. For example, progesterone may be more effective against some pathway that does not involve the uterine over-distention seen in twin pregnancy.

We need more research into the underlying causes of prematurity to help women with other risk factors, Dr. Katz said.


'"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
1-Aug-2007


Page: 1

Related biology news :

1. Progesterone injections do not prevent preterm birth in twin pregnancies
2. Testosterone replacement therapy: How safe for aging men?
3. Aggressive therapy best for certain AML patients
4. Under magnetic force, nanoparticles may deliver gene therapy
5. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Stem cell therapy rescues motor neurons in ALS model
7. Study identifies new gene therapy tools for inherited blindness
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
10. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... ... , ... The LaunchPort™ announced today that ExoRenal ( http://www.exorenal.com ... The newly formed company is developing a novel pulsatile hemodialysis technology that is ... dialysis treatments. The start-up company will be moving research functions from New England ...
(Date:2/5/2020)... ... 04, 2020 , ... Crystal Diagnostics (CDx) announced today that ... related to proprietary liquid crystal technology for rapid and accurate detection of foodborne ... on December 3, 2019. Together, these patents protect the company’s liquid crystal technology ...
(Date:1/29/2020)... ... 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the recognized ... a record earnings year for 2019. With final numbers to be released to ... increase in revenue and a thirty percent increase in gross profit, and more ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® ... by The National Organization for Rare Disorders (NORD), to raise awareness amongst the general ... ). The Balancing Act’s “Behind The Mystery” rare disease series will be ...
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle ... to food and beverage manufactures within North America. Both Lifecycle and Midland have ... will allow each company to pool their collective resources and provide the industry ...
(Date:1/27/2020)... PORTLAND, Ore. (PRWEB) , ... January 27, 2020 ... ... the latest advances in neuroscience and cloud and mobile computing, today announced the ... leaders from across an organization to use the latest neuroscience of leadership and ...
(Date:1/24/2020)... ... 24, 2020 , ... The impact of new medicines, procedures, ... and clinical services during the first two decades of the 21st century have ... Slone Partners celebrates its 20th anniversary this year, its evolution as a ...
Breaking Biology Technology:
Cached News: